Skip to content
AwardedSpainGoods€8,869,559

Acuerdo Marco del Suministro de ANTICUERPOS MONOCLONALES PARA EL TRATAMIENTO DE LA PROFILAXIS DE LA MIGRAÑA del Consorci de Salut i d'Atenció Social de Catalunya

Published
Published 8 July 2025
Deadline
Closed 8 August 2025

Overview

The Consorci de Salut i d'Atenció Social de Catalunya procured monoclonal antibodies for migraine prophylaxis treatment under a framework agreement valued at €8,869,559. The contract was awarded on 20 October 2025 to three suppliers: Lundbeck España, S.A.U., ORGANON SALUD, S.L., and TEVA PHARMA.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€8,869,559
Procedure
Open
Published
8 July 2025
Deadline
Closed
Classification (CPV)
Various medicinal products

Award outcome

Award date
20 October 2025
Contract period
— → 15 October 2026
Winners
  • Lundbeck España, S.A.U.
  • ORGANON SALUD, S.L.
  • TEVA PHARMA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    21 October 2025

  2. Contract Notice

    8 July 2025

Contracting authority

  • Consorci de Salut i d'Atenció Social de Catalunya

    Procuring entity

    Barcelona, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Acuerdo Marco del Suministro de ANTICUERPOS MONOCLONALES PARA EL TRATAMIENTO DE LA PROFILAXIS DE LA MIGRAÑA del Consorci de Salut i d'Atenció Social de Catalunya — won by Lundbeck España, S.A.U. +2 — Skim